Effect of direct vasodilatation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure the Hy-C trial von FONAROW, G. C, CHELIMSKY-FALLICK, C, WARNER STEVENSON, L, LUU, M, HAMILTON, M. A, MOMRIGICHI, J. D, TILLISCH, J. H, WALDEN, J. A, ALBANESE, E

Volltext